View Older Stories View More Recent Stories
-
Philip Morris reaffirms 2025 earnings forecast of $7.39-$7.49 per share
-
Philip Morris restructures into U.S. and international units
-
British American Tobacco Postpones Plan To Launch Unlicensed Vape In US, Reynolds Spokesperson Says - Reuters
-
Stifel Reiterates Philip Morris (PM) at Buy, Says PMI Topline, EPS Growth Profile Favourable to Peers
-
Goldman Sachs Reiterates Buy Rating on Philip Morris (PM)
-
Philip Morris (PM) PT Lowered to $175 at Morgan Stanley
-
Philip Morris International (PM) call put ratio 1.1 calls to 1 put as share price down 4.4%
-
Stifel on Philip Morris (PM): 'We view the pullback in the shares as an attractive buying point'
-
Philip Morris International (PM) Tops Q3 EPS by 15c, Beats on Revenue
-
Philip Morris earnings preview Q3: strong print expected amid Zyn momentum
-
Philip Morris International seeks FDA panel support for IQOS renewal
-
Philip Morris invests $37 million in Wilson NC manufacturing facility
-
Philip Morris International (PM) Raises Quarterly Dividend 8.9% to $1.47; 3.6% Yield
-
Philip Morris (PM) PT Lowered to $166 at UBS
-
Citi Adjust Catalyst Call List
-
Philip Morris reaffirms 2025 earnings guidance at investor conference
-
Aon plc (AON) Added to Goldman Director's Cut US Conviction List
-
Stifel Reiterates Buy Rating on Philip Morris (PM)
-
Stifel Reiterates Buy Rating on Philip Morris (PM)
-
Philip Morris International (PM) Tops Q2 EPS by 5c, Misses on Revenue; offers FY25 EPS Guidance
-
Philp Morris earnings preview Q2: stronger print expected on smoke-free portfolio gains
-
Philip Morris (PM) PT Raised to $200 at Goldman Sachs
-
Philip Morris (PM) PT Raised to $181 at UBS
-
Philip Morris (PM) PT Raised to $200 at Citi
-
Jefferies Starts Philip Morris (PM) at Buy
-
BofA's momentum indicator lists top-ranked stocks globally
-
Goldman rolls out latest U.S. Conviction List update
-
Stifel on Philip Morris (PM): 'We come away from the meetings with a positive bias toward PMI’s developing multi-category approach'
-
Philip Morris International (PM) Declares $1.35 Quarterly Dividend; 2.9% Yield
-
UBS Reiterates Neutral Rating on Philip Morris (PM)
-
Philip Morris (PM) PT Raised to $200 at BofA Securities
-
Philip Morris International (PM) reaffirms its 2025 full-year reported diluted EPS forecast
-
What stocks and implied dividends may indicate when it comes to recession risk
-
UBS upgrades Philip Morris on margin improvement at Zyn and IQOS
-
UBS Upgrades Philip Morris (PM) to Neutral
-
Philip Morris (PM) PT Raised to $186 at Stifel
-
Philip Morris International (PM) Tops Q1 EPS by 9c, Beats on Revenue
-
Philip Morris International (PM) call put ratio 3.7 calls to 1 put with a focus on May 165 calls into quarter results
-
Philip Morris International (PM) call put ratio 1.8 calls to 1 put into quarter results
-
Philip Morris (PM) PT Raised to $130 at UBS
-
Philip Morris International (PM) U.S. Launches IQOS
-
Philip Morris International (PM): Court Approves CCAA Plans to Resolve Tobacco Product-Related Claims and Litigation in Canada
-
Philip Morris International (PM) reaffirms its 2025 full-year reported diluted EPS forecast
-
Philip Morris (PM) PT Raised to $163 at Citi
-
Philip Morris (PM) PT Raised to $160 at Stifel
-
Stifel Out Positive on Philip Morris (PM) Following Earnings, 'FY25 Profit Outlook Above Medium-Term Targets'
-
Philip Morris International (PM) Misses Q4 EPS by 1c
-
Philip Morris International (PM) call put ratio 3.4 calls to 1 put with a focus on February 7 weekly calls into quarter results
-
Menthol Cigarette Ban Withdrawn By Trump Administration - Bloomberg
-
FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S.
